Gary S. Leiserowitz, M.D.

Clinical/Research Interests

Gary S. Leiserowitz and his colleagues in the Division of Gynecologic Oncology believe in patient-centered care that is anchored in the most current evidence-based medicine. He works closely with other physicians in medical oncology, radiation oncology and pathology to bring a multidisciplinary focus to each patient's case. His extensive surgical experience includes minimally invasive and robotic-assisted procedures for a variety of conditions. As director of the gynecologic oncology fellowship program at UC Davis, Leiserowitz is also helping train the next generation of specialists in cancers of the female reproductive system.

Title:

Professor and Chief, Gynecologic Oncology, Fellowship Director. Gynecologic Oncology

Specialty:

Gynecology Oncology, Cancer, Obstetrics and Gynecology

Center/Program Affiliation:

Robotic Surgery Program, UC Davis Comprehensive Cancer Center

Address:

UC Davis Comprehensive Cancer Center
4501 X St., Suite 2nd floor
Sacramento, CA 95817

Phone:

(916) 734-6941

Other Languages:

Spanish

Education:

University of Iowa College of Medicine
Iowa City, Iowa
M.D. 1981

Mayo Graduate School of Medicine
Rochester, Minnesota
M.S. 1993

University of Iowa
Iowa City, Iowa
B.S. 1976

Internships:

Ventura County Medical Center
Ventura, California
1981-1982

Residency:

UC Davis Medical Center, Chief Resident
Sacramento, California
1988-1989
Obstetrics and Gynecology

UC Davis Medical Center
Sacramento, California
1986-1988
Obstetrics and Gynecology

Ventura County Medical Center
Ventura, California
1982-1984
Family Practice

Fellowships:

Mayo Clinic
Rochester, Minnesota
1990-1993
Obstetrics and Gynecology, Gynecologic Oncology

Board Certifications:

American Board of Obstetrics and Gynecology, Gynecologic Oncology, 2002
American Board of Obstetrics and Gynecology, 1994
American Board of Family Medicine, 1984

Professional Memberships:

American Board of Obstetrics and Gynecology (ABOG), board examiner for specialty and sub-specialty
American College of Obstetricians and Gynecologists
Society of Gynecologic Oncologists
Western Association of Gynecologic Oncologists, President, 2008

Honors and Awards:

Recipient, “Best Doctors in America – 2005-2006” designation, October, 2005
Recipient, “Best Doctors in America – 2003-2004” designation, October, 2003
Recipient, Sutter Medical Center, Staff-Physician Appreciation Dinner Award, October, 2002
National Faculty Award, American College of Obstetricians and Gynecologists and Council on Resident Education in Obstetrics and Gynecology, June, 2002
Recipient, American Cancer Society Clinical Oncology Fellowship Award, 1991-1992
Outstanding Resident of the Year Award, Obstetrics and Gynecology, UC Davis Medical Center, 1989
Graduated with Distinction, B.S. degree, University of Iowa, 1976
Honors degree in Psychology, University of Iowa, 1976
Honors grant for undergraduate education, University of Iowa, 1976

Select Recent Publications:

Barkauskas, DA, An, HJ, Kronewitter, SR, Lorna de Leoz, M, Chew, HK, de Vere White, RW, Leiserowitz, GS, Miyamoto, S, Lebrilla, CB, and Rocke, DM. Detecting glycan cancer biomarkers in serum samples using MALDI FT-ICR mass spectrometry data. Bioinformatics 25(2):251-257, 2009.

Kronewitter, SR, An, HJ, Lorna de Leoz, M, Lebrilla, CB, Miyamoto, S, and Leiserowitz, GS. The development of retrosynthetic glycan libraries to profile and classify the human serum N-linked glycome. Proteomics 9: 2986-2994, 2009.

Leiserowitz GS, Xing G, Parikh-Patel A, Cress R, Abidi A, Rodriguez AO, Dalrymple JL. Laparoscopic Versus Abdominal Hysterectomy for Endometrial Cancer: Comparison of Patient Outcomes. International Journal of Gynecological Cancer, 19:1370-76, 2009.

Leiserowitz GS, Lebrilla C, Miyamoto S, An HJ, Duong H, Kirmiz C, Li B, Liu H, Lam KS. Glycomics analysis of serum: a potential new biomarker for ovarian cancer? Int J Gynecol Cancer, 18(3): 470-475, 2008.

Chan JK, Kapp DS, Shin JY, Osann K, Leiserowitz GS, Cress RD, O'Malley C. Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancer. Gynecol Oncol, 108(1): 95-99, 2008.

Guiou M, Hall WH, Konia T, Scudder S, Leiserowitz G, Ryu JK. Primary clear cell adenocarcinoma of the rectovaginal septum treated with concurrent chemoradiation therapy: a case report. Int J Gynecol Cancer. Sep-Oct;18(5):1118-21, 2008.

Chan, JK, Kapp, DS, Shin, JY, Husain, A, Teng, NN, Berek, JS, Osann, K, Leiserowitz, GS, Cress, R, and O’Malley, CO. Influence of the gynecologic oncologist on the survival of ovarian cancer patients. Obstet Gynecol, 109(6): 1342-50, 2007.

Elliott KS, Borowsky ME, Malka ES, Scudder SA, Leiserowitz GS, Russell AH. Long-term results of maximally aggressive trimodality therapy in a high-risk subset of early-stage cervical cancer patients. J Reprod Med. 51(5):383-8, 2006.

Leiserowitz, GS. Managing ovarian masses during pregnancy. Obstet Gynecol Surv. 61(7):463-70, 2006.

An HJ, Miyamoto S, Lancaster KS, Kirmiz C, Li B, Lam KS, Leiserowitz GS, Lebrilla CB. Profiling of Glycans in Serum for the Discovery of Potential Biomarkers for Ovarian Cancer. J Proteome Res. 7;5(7):1626-1635, 2006.